PapersPMID:36358485
A Randomized Controlled Trial on Pleurotus eryngii Mushrooms with Antioxidant Compounds and Vitamin D2 in Managing Metabolic Disorders.
What moved
1 findingHow to read these marks →“IL-6 and oxLDL decreased in the intervention group after 3 months and remained unchanged in the control group, with the mean changes being significantly different between the two groups.”
- Study
- RCT
- Dose studied
- snack consumed daily for 3 months; 6 g per sachet (sachets per day not stated)
- Population
- 100 metabolically unhealthy adults (aged 18-76) with metabolic disorders in Athens, randomised to the mushroom snack plus standard nutritional counseling or to counseling alone; the 3-month change in each arm was compared
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Metabolically unhealthy adults aged 18 to 76 years with metabolic disorders, Athens, Greece; baked, UV-B-irradiated Pleurotus eryngii snack (vitamin D2 enriched) added to standard nutritional counseling
- Participants
- 100
- Comparator
- no treatment
- Duration
- 91 days
- Endpoints measured
- 21